Condition
Malignant Mesothelioma
Estimated Enrollment: 47
Age Group: 18 Years and older (Adult, Senior)
Gender: All
Study Type: Interventional
Study Design Allocation: Intervention Model: Single Group Assignment|Masking: Open Label|Primary Purpose: Treatment
Study ID Numbers: CALGB-30107|U10CA031946|CDR0000269537
Study First Received: February 5, 2003
Last Updated: June 30, 2016
Estimated Primary Completion Date: July 2005
Primary Outcome Measures:
Survival|Failure free survival
Sponsors and Collaborators:
Alliance for Clinical Trials in Oncology|National Cancer Institute (NCI)
Website Link: https://ClinicalTrials.gov/show/NCT00053885
